ESC 2012

PARAMOUNT: Promising results of double action drug treatment for patients with heart failure and preserved ejection fraction .

Editorial Comment: This Phase II study included 149 patients following these criteria: NYHA II-IV heart failure, +40...

Aldo-DHF: Aldosterone Receptor Blockade in Diastolic Heart Failure Treatment

Editorial Comment: Fifty per cent of all HF patients involves Diastolic Heart Failure or HF with conserved...

ESC 2012.

Summary of the presentations, original articles and major slides shown at an event which was, without question,...